Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Visceral Leishmaniasis”

6 trials

Showing 6 of 6 results

Testing effectiveness (Phase 2)Study completedNCT05957978
What this trial is testing

LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study

Who this might be right for
Primary Visceral Leishmaniasis
Drugs for Neglected Diseases 52
Testing effectiveness (Phase 2)Study completedNCT05593666
What this trial is testing

A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis

Who this might be right for
Primary Visceral Leishmaniasis
Drugs for Neglected Diseases 101
Not applicableStudy completedNCT05449717
What this trial is testing

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Who this might be right for
LeishmaniasisLeishmaniasis, VisceralPost-kala-azar Dermal Leishmaniasis
Epicentre 52
Testing effectiveness (Phase 2)Study completedNCT02431143
What this trial is testing

Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 30
Large-scale testing (Phase 3)Study completedNCT03129646
What this trial is testing

Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 439
Testing effectiveness (Phase 2)Study completedNCT01067443
What this trial is testing

Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa

Who this might be right for
Primary Visceral Leishmaniasis
Drugs for Neglected Diseases 151

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation